General Information of Drug (ID: DMQESM7)

Drug Name
Cordil Drug Info
Synonyms LND-796; LNF-209
Indication
Disease Entry ICD 11 Status REF
Heart arrhythmia BC65 Terminated [1]
Cross-matching ID
PubChem CID
3081161
CAS Number
CAS 118549-42-1
TTD Drug ID
DMQESM7

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Digoxin DMQCTIH Arrhythmia BC9Z Approved [3]
Digitoxin DMWVIGP Arrhythmia BC9Z Approved [4]
Sanguinarine DMDINFS Dental plaque DA08.4 Approved [5]
Rostafuroxin DMKQXDB Hypertension BA00-BA04 Phase 2 [6]
PBI-05204 DM05WIU Pancreatic cancer 2C10 Phase 2 [7]
RX108 DM4XETK Solid tumour/cancer 2A00-2F9Z Phase 1 [8]
Istaroxime DMWN09H Cardiac disease BA00-BE2Z Discontinued in Phase 2 [9]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sodium/potassium-transporting ATPase (SPT ATPase) TTQ38E9 AT1A1_HUMAN; AT1A2_HUMAN; AT1A3_HUMAN; AT1B1_HUMAN; AT1B2_HUMAN; AT1B3_HUMAN Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001241)
2 WO patent application no. 1995,0085,58, Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds.
3 Fab antibody fragments: some applications in clinical toxicology. Drug Saf. 2004;27(14):1115-33.
4 Treatment of congestive heart failure--current status of use of digitoxin. Eur J Clin Invest. 2001;31 Suppl 2:10-7.
5 Medicinal plants in therapy. Bull World Health Organ. 1985;63(6):965-81.
6 Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension. Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R529-35.
7 First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf- beta and p70s6k, in patients with advanced solid tumors. Invest New Drugs. 2014 Dec;32(6):1204-12.
8 ClinicalTrials.gov (NCT03646071) A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors. U.S. National Institutes of Health.
9 Novel analogues of istaroxime, a potent inhibitor of Na+,K+-ATPase: synthesis and structure-activity relationship. J Med Chem. 2008 Aug 14;51(15):4601-8.